These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 21892857

  • 21. Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients.
    Stewart DE, Wohlreich MM, Mallinckrodt CH, Watkin JG, Kornstein SG.
    J Affect Disord; 2006 Aug; 94(1-3):183-9. PubMed ID: 16780958
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.
    Zhao Y, Sun P, Watson P, Mitchell B, Swindle R.
    Pain Pract; 2011 Aug; 11(3):204-16. PubMed ID: 20807351
    [Abstract] [Full Text] [Related]

  • 24. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
    Gore M, Tai KS, Chandran A, Zlateva G, Leslie D.
    J Med Econ; 2012 Aug; 15(1):19-31. PubMed ID: 21970699
    [Abstract] [Full Text] [Related]

  • 25. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 26. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
    Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.
    Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
    Greist J, McNamara RK, Mallinckrodt CH, Rayamajhi JN, Raskin J.
    Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
    [Abstract] [Full Text] [Related]

  • 30. Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine.
    Wu N, Chen S, Boulanger L, Rao P, Zhao Y.
    Curr Med Res Opin; 2011 Jun; 27(6):1131-9. PubMed ID: 21456939
    [Abstract] [Full Text] [Related]

  • 31. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV, Joish VN, Camacho F, Drake CL.
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [Abstract] [Full Text] [Related]

  • 32. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM, Meyers AL, Sunderajan P, Montano CB, Kass E, Trivedi M, Wohlreich MM.
    Ann Clin Psychiatry; 2008 Aug; 20(4):187-93. PubMed ID: 19034749
    [Abstract] [Full Text] [Related]

  • 33. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, Chappell AS.
    Clin J Pain; 2009 Aug; 25(6):461-8. PubMed ID: 19542792
    [Abstract] [Full Text] [Related]

  • 34. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
    Sun P, Zhao Y, Zhao Z, Watson P.
    Curr Med Res Opin; 2011 Sep; 27(9):1793-801. PubMed ID: 21810060
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.
    Perahia DG, Kajdasz DK, Desaiah D, Haddad PM.
    J Affect Disord; 2005 Dec; 89(1-3):207-12. PubMed ID: 16266753
    [Abstract] [Full Text] [Related]

  • 39. Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder.
    Fava M, Wiltse C, Walker D, Brecht S, Chen A, Perahia D.
    J Affect Disord; 2009 Mar; 113(3):263-71. PubMed ID: 18625521
    [Abstract] [Full Text] [Related]

  • 40. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC.
    Depress Anxiety; 2010 Mar; 27(1):12-8. PubMed ID: 20013987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.